Physician profile
Richard Rainey
NPI 1063624948
$760.15
in general payments reported to CMS, 2019-2025
16 companies · $79.21 in 2025
The $79.21 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $196 · 2021: $11.98 · 2022: $108 · 2024: $73.78 · 2025: $79.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gentleman Orthopedic Solutions | $165.26 | 2019-2020 | |
| Pacira Therapeutics, INC. | $91.05 | 2019-2020 | |
| Bioventus LLC | $67.30 | 2021-2025 | Xcell, Exogen Ultrasound Bone Healing System |
| Innovation Technologies INC | $55.77 | 2025 | Irrisept |
| Depuy Synthes Sales INC. | $54.21 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $51.07 | 2019-2020 | |
| Boston Scientific Corporation | $45.07 | 2022-2024 | |
| Endo Pharmaceuticals INC. | $45.05 | 2019-2020 | |
| Smith+Nephew, INC. | $33.92 | 2019 | |
| Baxter Healthcare | $33.27 | 2022 | |
| Stryker Corporation | $32.83 | 2022 | |
| Abbvie INC. | $19.89 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $18.49 | 2024 | Iovera, Exparel |
| Convatec INC. | $17.05 | 2019 | |
| Avanos Medical | $16.60 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $13.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Rainey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.